Trials / Unknown
UnknownNCT01095770
Left Atrial Ablation With Permanent Pacemaker or ImplanTable Loop Recorder Follow-UP
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Eastbourne General Hospital · Academic / Other
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is 3 fold:- 1. To compare the efficacy and complication rates of 2 widely used methods, conventional irrigation tip ablation catheter (LASSO) and Ablation Frontiers ablation technology, of AF ablation for PAF. 2. To evaluate the Reveal XT ILR as a long term accurate AF monitoring device as compared to the 'gold standard' DDD pacemaker Holter. 3. To accurately evaluate, by continuous rhythm monitoring for 1 year, the efficacy of AF ablation therapy for PAF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | AF Ablation with Ablation Frontiers Technology | AF Ablation with Ablation Frontiers Technology - PVAC, TVAC and MASC. |
| PROCEDURE | AF Ablation with LASSO catheter | AF Ablation with traditional LASSO catheter |
| DEVICE | Reveal XT | Reveal XT implantable loop recorder monitored group |
| DEVICE | Permanent Dual Chamber Pacemaker | This group will be monitored with a dual chamber pacemaker with advanced AF monitoring capabilities. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-04-01
- Completion
- 2012-11-01
- First posted
- 2010-03-30
- Last updated
- 2010-03-30
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01095770. Inclusion in this directory is not an endorsement.